Repurposing mosloflavone/5,6,7-trimethoxyflavone-resveratrol hybrids: Discovery of novel p38-α MAPK inhibitors as potent interceptors of macrophage-dependent production of proinflammatory mediators
Author:
Funder
National Research Foundation of Korea
Ministry of Education, Science and Technology
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference105 articles.
1. Drug repositioning: identifying and developing new uses for existing drugs;Ashburn;Nat. Rev. Drug Discov.,2004
2. NCATS launches drug repurposing program;Allison;Nat. Biotechnol.,2012
3. EGFR inhibitors from cancer to inflammation: discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor;Elkamhawy;Bioorg. Chem.,2019
4. Repositioning of the antipsychotic trifluoperazine: synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents;Kang;Eur. J. Med. Chem.,2018
5. See, cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: a nationwide population-based dynamic cohort study in Taiwan;Yu;Medicine,2016
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery of a stilbenoid-flavanone hybrid as an antitumor Wnt/β-catenin signaling pathway inhibitor;Bioorganic Chemistry;2024-02
2. Function and inhibition of P38 MAP kinase signaling: Targeting multiple inflammation diseases;Biochemical Pharmacology;2024-02
3. Flavone Hybrids and Derivatives as Bioactive Agents;Applied Sciences;2024-01-25
4. Flavonoid diversity and roles in the lipopolysaccharide-mediated inflammatory response of monocytes and macrophages;Future Medicinal Chemistry;2024-01
5. Repurposing of conformationally-restricted cyclopentane-based AKT–inhibitors leads to discovery of potential and more selective antileishmanial agents than miltefosine;Bioorganic Chemistry;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3